July 2018

AJMCtv® Interviews, July 2018

July 26, 2018

Evidence-Based Oncology

AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers—from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. Access the video clips at ajmc.com/interviews.

Researchers Report Findings on Three Biosimilar Trastuzumab Products

July 25, 2018

Evidence-Based Oncology

During the 2018 American Society of Clinical Oncology’s (ASCO) Annual Meeting, researchers presented findings on 3 biosimilar trastuzumab products: Samsung Bioepis’ SB3, Agmen’s ABP 980, and Biocad’s Herticad.

Robotic Surgery Complements Chemotherapy, Safer Than Radiation, in Oral Cancer

July 18, 2018

Evidence-Based Oncology

Results presented at the 2018 American Society of Clinical Oncology's Annual Meeting found that transoral robotic-assisted surgery (TORS), following chemotherapy and neck resections, is an effective model for the definitive treatment for oropharyngeal squamous cell carcinoma (OPSCC) while avoiding the adverse effects of radiation.